Sort   by:  
 Page size 
UnknownFree, healthy school lunches in New Zealand: A Value for Investment analysis.
Not available
S-EPMC12539167 | biostudies-literature
UnknownNocturnal short-term heart rate variability reflects impaired daytime vigilance better than overnight heart rate variability in suspected obstructive sleep apnea patients.
Not available
S-EPMC11985393 | biostudies-literature
UnknownOcean Surface Flux Algorithm Effects on Tropical Indo-Pacific Intraseasonal Precipitation.
Not available
S-EPMC9286826 | biostudies-literature
ProteomicsIlluminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics-2
Kinase inhibitors (KIs) are important cancer drugs but often display polypharmacology that is molecularly not understood. This disconnect is particularly apparent in cancer entities such as sarcomas for which the oncogenic drivers are often not clear. To investigate more systematically how the cellu...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-11-29 | MSV000093533 | MassIVE
ProteomicsIlluminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics
Kinase inhibitors (KIs) are important cancer drugs but often display polypharmacology that is molecularly not understood. This disconnect is particularly apparent in cancer entities such as sarcomas for which the oncogenic drivers are often not clear. To investigate more systematically how the cellu...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2023-01-11 | MSV000091043 | MassIVE
UnknownPathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment.
Not available
S-EPMC8509647 | biostudies-literature
UnknownCardiopulmonary coupling indices to assess weaning readiness from mechanical ventilation.
Not available
S-EPMC8346488 | biostudies-literature
MetabolomicsFecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has not been evaluated. We conducted a multicenter phase I trial combining ...

2025-02-27 | MTBLS711 | MetaboLights
UnknownThe Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.
Not available
S-EPMC6433978 | biostudies-literature
UnknownCurrent Understanding of the Role of Complement in IgA Nephropathy.
Not available
S-EPMC4483595 | biostudies-literature
Sort   by:  
 Page size